Boston scientific receives fda approval for farapulse™ pulsed field ablation system

Strong clinical evidence base, largest volume of real-world use reinforce  safety, efficacy and efficiency advantages of the system marlborough, mass. , jan. 31, 2024 /prnewswire/ -- boston scientific corporation (nyse: bsx) announced it has received u.s. food and drug administration (fda) approval for the farapulse™ pulsed field ablation (pfa) system.
BSX Ratings Summary
BSX Quant Ranking